Fisher MJ - Search Results

1

Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial.

Paton NI, Goodall RL, Dunn DT, Franzen S, Collaco-Moraes Y, Gazzard BG, Williams IG, Fisher MJ, Winston A, Fox J, Orkin C, Herieka EA, Ainsworth JG, Post FA, Wansbrough-Jones M, Kelleher P; Hydroxychloroquine Trial Team. Paton NI, et al. Among authors: fisher mj. JAMA. 2012 Jul 25;308(4):353-61. doi: 10.1001/jama.2012.6936. JAMA. 2012. PMID: 22820788 Free PMC article. Clinical Trial.

2

The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection.

Nelson MR, Fisher M, Cartledge J, Rogers T, Gazzard BG. Nelson MR, et al. AIDS. 1994 May;8(5):651-4. doi: 10.1097/00002030-199405000-00011. AIDS. 1994. PMID: 8060545 Review.

3

Pulmonary diseases and HIV infection.

Fisher M, Asboe D, Gazzard BG. Fisher M, et al. Thorax. 1996 Feb;51(2):228. doi: 10.1136/thx.51.2.228-a. Thorax. 1996. PMID: 8711668 Free PMC article. No abstract available.

4

New treatments for progressive multifocal leukoencephalopathy in HIV-1-infected patients.

Sadler M, Chinn R, Healy J, Fisher M, Nelson MR, Gazzard BG. Sadler M, et al. AIDS. 1998 Mar 26;12(5):533-5. AIDS. 1998. PMID: 9543455 No abstract available.

5

Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine.

Sabin CA, Fisher M, Churchill D, Pozniak A, Hay P, Easterbrook P, Williams I. Sabin CA, et al. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):462-5. doi: 10.1097/00126334-200104150-00009. J Acquir Immune Defic Syndr. 2001. PMID: 11391166 Clinical Trial.

6

Cessation of secondary prophylaxis in patients with cryptococcosis.

Nwokolo NC, Fisher M, Gazzard BG, Nelson MR. Nwokolo NC, et al. AIDS. 2001 Jul 27;15(11):1438-9. doi: 10.1097/00002030-200107270-00015. AIDS. 2001. PMID: 11504967

7

Long-term follow-up: no effect of therapeutic vaccination with HIV-1 p17/p24:Ty virus-like particles on HIV-1 disease progression.

Lindenburg CE, Stolte I, Langendam MW, Miedema F, Williams IG, Colebunders R, Weber JN, Fisher M, Coutinho RA. Lindenburg CE, et al. Vaccine. 2002 May 22;20(17-18):2343-7. doi: 10.1016/s0264-410x(02)00102-0. Vaccine. 2002. PMID: 12009290 Clinical Trial.

8

Thymic activity in late-stage HIV-1 infected individuals receiving highly active antiretroviral therapy: potential effect of steroid therapy.

Pido-Lopez J, Pires A, Nelson M, O'Moore E, Fisher M, Gazzard B, Aspinall R, Gotch F, Imami N. Pido-Lopez J, et al. HIV Med. 2002 Jan;3(1):56-61. doi: 10.1046/j.1464-2662.2001.00093.x. HIV Med. 2002. PMID: 12059952 Free article.

9

Naively changing HAART.

Mandalia S, Parmar D, Fisher M, Pozniak A, Tang A, Youle M, Gazzard B, Beck EJ; NPMS-HHC Steering Group. Mandalia S, et al. HIV Med. 2002 Oct;3(4):254-62. doi: 10.1046/j.1468-1293.2002.00110.x. HIV Med. 2002. PMID: 12444943 Free article.

10

An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals.

Nelson M, Portsmouth S, Stebbing J, Atkins M, Barr A, Matthews G, Pillay D, Fisher M, Bower M, Gazzard B. Nelson M, et al. AIDS. 2003 Jan 3;17(1):F7-10. doi: 10.1097/00002030-200301030-00002. AIDS. 2003. PMID: 12478090 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters